WebIronwood Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will participate in the following investor conferences: Cowen 43rd Annual Health Care Conference on Monday, March 6, 2024 at … WebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate the role of COO, and Rickard's ...
IRONWOOD PHARMACEUTICALS, INC. : IRWD Stock Price
Web1 hour ago · The counties faced "severe conditions and sustained serious damage caused by widespread flooding," according to a news release sent by the governor's office Friday. … WebMay 6, 2024 · BOSTON-- (BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced today that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $150 million of its outstanding shares of common stock through December 2024. how many weeks since 1/11/23
Ironwood Pharmaceuticals LinkedIn
WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI … WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC. WebNov 4, 2024 · Ironwood Pharmaceuticals Reports Third Quarter 2024 Results and Provides Corporate Development Update – LINZESS® (Iinaclotide) prescription demand growth increased 12% year-over-year; LINZESS... how many weeks since 11/12/22